Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy
Manisha Ahir, Priyanka Upadhyay, Avijit Ghosh, et al.
Biomaterials Science (2020) Vol. 8, Iss. 10, pp. 2939-2954
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Non-coding RNAs and potential therapeutic targeting in cancer
Shusuke Toden, Timothy J. Zumwalt, Ajay Goel
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188491-188491
Open Access | Times Cited: 222
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 32
Applications and developments of gene therapy drug delivery systems for genetic diseases
Xiuhua Pan, Hanitrarimalala Veroniaina, Nan Su, et al.
Asian Journal of Pharmaceutical Sciences (2021) Vol. 16, Iss. 6, pp. 687-703
Open Access | Times Cited: 92
Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
Rafael R. Castillo, Daniel Lozano, Maria Vallet‐Regí
Pharmaceutics (2020) Vol. 12, Iss. 5, pp. 432-432
Open Access | Times Cited: 90
An Update on Mesoporous Silica Nanoparticle Applications in Nanomedicine
Elham Rastegari, Yu‐Jer Hsiao, Wei-Yi Lai, et al.
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 1067-1067
Open Access | Times Cited: 89
Molecular insights and novel approaches for targeting tumor metastasis
Sabya Sachi Das, Saad Alkahtani, Priyanshu Bharadwaj, et al.
International Journal of Pharmaceutics (2020) Vol. 585, pp. 119556-119556
Closed Access | Times Cited: 79
Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review
Juan L. Paris, Maria Vallet‐Regí
Pharmaceutics (2020) Vol. 12, Iss. 6, pp. 526-526
Open Access | Times Cited: 74
Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer
Yinan Ding, Rui Yang, Weiping Yu, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 57
Nanotechnology‐Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID‐19 Vaccines
Chiara Rinoldi, Seyed Shahrooz Zargarian, Paweł Nakielski, et al.
Small Methods (2021) Vol. 5, Iss. 9
Open Access | Times Cited: 56
Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives
Luis Alberto Bravo-Vázquez, Andrea Méndez-García, Alma L. Rodríguez, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 30
Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment
Sonali Shinde, Sakeel Ahmed, Jonaid Ahmad Malik, et al.
Biology (2023) Vol. 12, Iss. 3, pp. 467-467
Open Access | Times Cited: 23
Polymeric functionalization of mesoporous silica nanoparticles: Biomedical insights
Akhil K. Nair, Raghu Chandrashekhar H., Candace M. Day, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124314-124314
Open Access | Times Cited: 8
Glycans as Targets for Drug Delivery in Cancer
Francisca Diniz, Pedro Coelho, Henrique O. Duarte, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 911-911
Open Access | Times Cited: 36
Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer
Rajesh Pradhan, Anuradha Dey, Rajeev Taliyan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 246-246
Open Access | Times Cited: 20
Role of adhesion molecules in cancer and targeted therapy
Chunmei Fan, Fang Xiong, Shanshan Zhang, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 5, pp. 940-957
Closed Access | Times Cited: 6
Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer
Arijita Basu, Priyanka Upadhyay, Avijit Ghosh, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2021) Vol. 1865, Iss. 3, pp. 129841-129841
Closed Access | Times Cited: 39
Recent advances of polymer based nanosystems in cancer management
Chetan Janrao, Shivani Khopade, Akshay Bavaskar, et al.
Journal of Biomaterials Science Polymer Edition (2022) Vol. 34, Iss. 9, pp. 1274-1335
Closed Access | Times Cited: 25
Research progress on non-protein-targeted drugs for cancer therapy
Yiwen Zhang, Lu Lu, Feifeng Song, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 16
Engineered mesoporous silica nanoparticles, new insight nanoplatforms into effective cancer gene therapy
Razieh Heidari, Vahideh Assadollahi, Pegah Khosravian, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127060-127060
Closed Access | Times Cited: 14
Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders
Bhagavathi Sundaram Sivamaruthi, Subramanian Thangaleela, Periyanaina Kesika, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 439-439
Open Access | Times Cited: 13
Silica-Based Gene Delivery Systems: From Design to Therapeutic Applications
Ana Maria Carvalho, Rosemeyre A. Cordeiro, Henrique Faneca
Pharmaceutics (2020) Vol. 12, Iss. 7, pp. 649-649
Open Access | Times Cited: 39
Nanoparticle mediated RNA delivery for wound healing
Elayaraja Kolanthai, Yifei Fu, Udit Kumar, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 14, Iss. 2
Closed Access | Times Cited: 30
A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
Mahdi Abdoli Shadbad, Negar Hosseinkhani, Zahra Asadzadeh, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 27
Emerging innovations on exosome-based onco-therapeutics
Xiaofeng Dai, Yongju Ye, Fu-le He
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Recent advances in novel miRNA mediated approaches for targeting breast cancer
Seyedeh Melika Ahmadi, Shervin Amirkhanloo, Rezvan Yazdian–Robati, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 8, pp. 777-793
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top